California Business and Professions Code

§ 22949.51

BPC § 22949.51 Effective Jan 1, 2020Div. 8 · Ch. 37

Statute text

For purposes of this chapter, the following definitions apply:

(a)“Gene therapy” refers to the administration of genetic material to modify or manipulate the expression of a gene product, or to alter the biological properties of living cells, for therapeutic use.

(b)“Gene therapy kit” refers to a product that is sold as a collection of materials for the purpose of facilitating gene therapy experiments, including, but not limited to, a system for the targeted cutting of DNA molecules, such as type II clustered regularly interspaced short palindromic repeats (CRISPR), associated proteins (CRISPR-Cas) systems, including CRISPR-Cas9, as described in Regents of University of California v. Broad Institute, Inc. (2018) 903 F.3d 1286.

Legislative history

Added by Stats. 2019, Ch. 140, Sec. 2. (SB 180) Effective January 1, 2020.